Physician profile
Eric M Schilling
NPI 1740509348
$14,073.25
in general payments reported to CMS, 2019-2025
41 companies · $1,258 in 2025
The $1,258 reported for 2025 was more than what 81% of Critical Care Medicine (Internal Medicine) providers received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $750 · 2020: $2,595 · 2021: $4,540 · 2022: $891 · 2023: $1,643 · 2024: $2,396 · 2025: $1,258.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,171 · Travel and Lodging: $1,106 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,170.57 |
| Travel and Lodging | $1,106.47 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,811.90 | 2020-2024 | Da Vinci Surgical System |
| Pulmonx Corporation | $1,516.46 | 2023-2025 | Zephyr Endobronchial Valve, Zephyr Delivery Catheter, Chartis Catheter |
| Glaxosmithkline, LLC. | $1,179.69 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals Lp | $962.11 | 2019-2025 | Fasenra, Tezspire, Breztri |
| Actelion Pharmaceuticals US, INC. | $630.68 | 2019-2024 | Opsumit, Uptravi |
| Insmed, INC. | $453.09 | 2019-2025 | Arikayce, Brinsupri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $434.67 | 2019-2025 | Ofev, Jascayd |
| Regeneron Healthcare Solutions, INC. | $296.24 | 2021-2025 | Dupixent |
| Harmony Biosciences LLC | $248.35 | 2020-2022 | |
| Shionogi INC | $204.98 | 2020-2024 | Fetroja |
| Jazz Pharmaceuticals INC. | $186.73 | 2019-2022 | |
| United Therapeutics Corporation | $186.58 | 2019-2025 | Tyvaso, Orenitram, Remodulin |
| Amgen INC. | $173.40 | 2022-2025 | Tezspire |
| Takeda Pharmaceuticals U.S.A., INC. | $156.72 | 2021-2023 | Glassia |
| Genzyme Corporation | $151.55 | 2019-2025 |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $121.23 | 2023 | Opdivo |
| Sanofi US Services INC. | $121.21 | 2025 | |
| Abbvie INC. | $107.54 | 2022-2025 | |
| Grifols USA, LLC | $103.17 | 2021-2025 | Prolastin-C Liquid |
| Gilead Sciences, INC. | $86.86 | 2019-2023 | |
| Mylan Specialty L.P. | $85.23 | 2019-2023 | Yupelri |
| Sunovion Pharmaceuticals INC. | $75.18 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $71.37 | 2019-2022 | |
| Baxter Healthcare | $69.43 | 2023-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Monarch Airway Clearance System, Hillrom - Life 2000 Ventilation System |
| Janssen Pharmaceuticals, INC | $67.14 | 2021-2024 | Xarelto |
| Teva Pharmaceuticals USA, INC. | $65.03 | 2019-2020 | |
| Inspire Medical Systems, INC. | $54.17 | 2024-2025 | Inspire |
| Electromed, INC. | $50.45 | 2019-2025 | Smartvest |
| Portola Pharmaceuticals, LLC | $47.75 | 2019 | |
| Ambu INC. | $45.39 | 2020-2024 | |
| Pfizer INC. | $44.69 | 2019-2020 | |
| Verona Pharma, INC. | $44.57 | 2025 | Ohtuvayre |
| Merck Sharp & Dohme LLC | $42.56 | 2020-2023 | |
| Alexion Pharmaceuticals, INC. | $30.72 | 2021-2022 | |
| Philips North America LLC | $28.48 | 2019 | |
| Vapotherm INC | $27.90 | 2022 | |
| Novartis Pharmaceuticals Corporation | $27.77 | 2019-2020 | |
| Genentech USA, INC. | $17.78 | 2019 | |
| Inogen, INC. | $17.42 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Nuwellis, INC. | $15.82 | 2019 | |
| Allergan, INC. | $11.24 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Schilling listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.